Concepedia

Xiaoli Zhu

XZ

Statistics

Publications

21

Citations

764

H-Index

15

Active since

2010

Affiliations

Soochow University(Current)

First Affiliated Hospital of Soochow University

Nanjing Medical University

First Affiliated Hospital Zhejiang University

Fudan University

Xiaoli Zhu is an author at Soochow University specializing in oncology, medicine, and liver cancer.

ORCID

Publications per year

2010–2024

21

Publications

21

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu et al. · EClinicalMedicine · 2024 · 143 citations · Full text

, , +17

Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study

Zhi‐Cheng Jin, Bin‐Yan Zhong, Jian-Jia Chen et al. · European Radiology · 2023 · 88 citations · Full text

, , +14

Utility of the Amplatzer Vascular Plug in Splenic Artery Embolization: A Comparison Study with Conventional Coil Technique

Xiaoli Zhu, Matthew Tam, Gregory Pierce et al. · CardioVascular and Interventional Radiology · 2010 · 68 citations

, , +6

Retrievability and Device-Related Complications of the G2 Filter: A Retrospective Study of 139 Filter Retrievals

Xiaoli Zhu, Matthew Tam, John R. Bartholomew et al. · Journal of Vascular and Interventional Radiology · 2011 · 61 citations

, , +3

Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response

Fei Yang, Guili Xu, Jintao Huang et al. · Frontiers in Immunology · 2022 · 49 citations · Full text

, , +17

1–5 of 21